🌍 Society & Frontier risk-on · 1–3 years
A what‑if from the future

What if AI halves drug-discovery time?

AI-native discovery platforms cut preclinical timelines in half and push a wave of AI-originated drugs into Phase 1, compressing pharma R&D cost curves.

36%
our model probability
over 1–3 years
prediction markets — wisdom of the crowd
loading live odds…
Empirically anchored 36% · 90% range 3–68% · 14 analogues · measured class health 42% in 3 yr · 3% held back for the unknown
how we built this number — every step
Measured class rate — health ≈0.1843/yr → 42% in 3 yr42%
Analyst prior · editorial share 94% of the class40%
Pooled · weight 70%37%
Crowd — no liquid market
Reserve 3% · no extremizing (×1.0)37%
Published36%

The class rate is measured from our dated, sourced event library (decade-normalized Poisson — the full table is public at base_rates.json). The variant’s share within its class is the analyst’s editorial call, published so you can audit it. A wider range means thinner precedent. Full recipe: methodology · scored at Reality Check.

The butterfly cascade

How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.

Resolution timeline — how this probability is moving

Our model's odds (gold) over time vs the crowd's (Polymarket, blue), from the past toward the 1–3 years horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. The gold path is an illustrative reconstruction anchored to today's estimate — real dated events, not a live re-estimate history.

loading the timeline…

What it would mean

If this plays out, it is a risk-on shock. AI-native discovery platforms cut preclinical timelines in half and push a wave of AI-originated drugs into Phase 1, compressing pharma R&D cost curves. The trigger decomposes into signed root‑shocks — AI breakthrough ▲ · Biotech breakthrough ▲ · Scientific breakthrough ▲ — which propagate through our causal graph to the markets below.

If it happens — the markets it would move

Biggest moves first. Projected moves are cascade-model priors; hist A–B% = what comparable past events actually did (measured abnormal returns), and model prior · unmeasured marks markets with no analogue backing yet. Tap any market for its price history.

MarketClassProjected move
1Nvidia NVDAon Hyperliquid 📈 chartEquity▲ +2.2%
hist -1.82–+5.9% · other way -2.1% (n=12)
2Nasdaq 100 NDXon Hyperliquid 📈 chartIndex▲ +2.0%
hist +0.75–+1.66% · other way +0.08% (n=12)
3Semiconductors SMHon Hyperliquid 📈 chartEquity▲ +1.6%
hist +0.13–+2.05% · other way +0.84% (n=12)
4Tech sector XLK 📈 chartEquity▲ +1.3%
hist +0.13–+1.75% · other way +0.17% (n=12)
5AMD AMDon Hyperliquid 📈 chartEquity▲ +1.0%
hist -1.63–+1.69% · other way +2.56% (n=12)
6Broadcom AVGOon Hyperliquid 📈 chartEquity▲ +1.0%
hist -0.34–+2.02% · other way +3.97% (n=12)
7Micron MUon Hyperliquid 📈 chartEquity▲ +1.0%
hist -2.05–+2.68% · other way -1.48% (n=12)
8TSMC TSMon Hyperliquid 📈 chartEquity▲ +1.0%
hist -0.3–+1.92% · other way +0.61% (n=12)
9Marvell MRVLon Hyperliquid 📈 chartEquity▲ +1.0%
hist -0.96–+2.81% · other way +2.77% (n=12)
10ASML ASMLon Hyperliquid 📈 chartEquity▲ +0.8%
hist -0.4–+1.77% · other way -1.89% (n=12)
11S&P 500 SPXon Hyperliquid 📈 chartIndex▲ +0.7%
hist -0.13–+1.24% · other way -3.71% (n=12)
12Solana SOLon Hyperliquid 📈 chartCrypto▲ +0.7%
hist -11.96–+5.08% · other way -12.47% (n=10)
13Hyperliquid (HYPE) HYPEon HyperliquidCrypto▲ +0.6%
model prior · unmeasured
14MicroStrategy MSTRon Hyperliquid 📈 chartEquity▲ +0.7%
hist -7.9–+15.01% · other way +7.83% (n=12)

Probable recommendation

If the scenario above plays out, the probable cross‑asset positioning → a scenario‑conditional read, not personalized investment advice
For a common-man portfolio: A typical stock-heavy portfolio should benefit. Stay invested; you can lean modestly into the beneficiaries below.
Also moves (not yet on Hyperliquid): Tech sector +1.3% · High-yield credit +0.2%

Historical precedent — what analogous events actually did

Across 14 analogous events (overlap‑weighted), as abnormal returns — market beta stripped, so it's the event's own effect, not the market backdrop. Shown at 20 days (persistent) and 5 days (immediate); ↺ fades = the two horizons disagree. Confidence = consistency × sample × significance.

Wegovy 2021-06 First mRNA COVID-19 vaccine authorized 2020-12 AlphaFold cracks the protein-folding problem 2020-11 Neuralink implants its first human brain-computer interface 2024-01 Casgevy — first CRISPR gene-editing medicine approved 2023-12 mRNA pioneers win the Nobel 2023-10 OpenAI releases GPT-4 2023-03 ChatGPT launches 2022-11 First genetically-modified pig-to-human heart transplant 2022-01 AlphaGo defeats Lee Sedol 2016-03 Human Genome Project completed 2003-04 LK-99 room-temperature superconductor claim 2023-07 Nvidia AI-guidance blowout ignites the automation/AI capex wave 2023-05 SpaceX lands an orbital rocket booster 2015-12
AssetHistory saysAbnormal (20d · 5d)HitnConfidencevs cascade
SOL SOLSHORT-11.6% · 5d -10.0%82%11 0.49⚠ differs
SPX SPXLONG+0.8% · 5d +1.3%69%14 0.34✓ matches cascade
US dollar DXYSHORT-0.8% · 5d -0.7%71%14 0.33·
QCOM QCOMSHORT-2.9% · 5d -1.4%74%14 0.29⚠ differs
AVGO AVGOLONG+1.3% · 5d -0.3% ↺ fades64%13 0.22✓ matches cascade
MSTR MSTRLONG+14.7% · 5d +0.6%62%14 0.22✓ matches cascade
Bitcoin BTCLONG+6.4% · 5d -4.6% ↺ fades62%13 0.21✓ matches cascade
AMD AMDSHORT-2.3% · 5d +1.1% ↺ fades64%14 0.18⚠ differs
INTC INTCSHORT-0.4% · 5d +0.9% ↺ fades62%14 0.17⚠ differs
High-yield credit HYGSHORT-0.3% · 5d -0.3%64%13 0.17⚠ differs
Gold XAULONG+0.8% · 5d +0.2%57%14 0.11·
SMH SMHLONG+0.9% · 5d +1.3%57%14 0.10✓ matches cascade
10y yield DGS10LONG+4bp · 5d -3bp ↺ fades57%14 0.10·
NDX NDXLONG+0.2% · 5d -0.3% ↺ fades57%14 0.09✓ matches cascade

Methodology. Probability and impact are anchored to history and scored against what actually happens — wins and losses, in public, at Reality Check. Crowd odds live from Polymarket & Kalshi. By Vikas Singh, Quantitative Strategist. Updated 2026-07-03.